Poseida Therapeutics Up Nearly 225%, On Pace For Record High Close -- Data Talk

Dow Jones11-26 23:03

Poseida Therapeutics, Inc. (PSTX) is currently at $9.29, up $6.43 or 224.78%

 

--Would be highest close since Aug. 30, 2021, when it closed at $10.71

--Would be largest percent increase on record (Based on available data back to July 10, 2020)

--Currently up three consecutive days; up 242.76% over this period

--Best three day stretch on record (Based on available data back to July 10, 2020)

--Up 291.93% month-to-date; on pace for best month on record (Based on available data back to July 10, 2020)

--Up 176.45% year-to-date; on pace for best year on record (Based on available data back to July 10, 2020)

--Down 42.84% from its all-time closing high of $16.25 on July 20, 2020

--Up 250.52% from 52 weeks ago (Nov. 28, 2023), when it closed at $2.65

--Would be a new 52-week closing high

--Up 364.44% from its 52-week closing low of $2.00 on April 18, 2024

--Traded as high as $9.32; highest intraday level since Aug. 31, 2021, when it hit $10.89

--Up 225.87% at today's intraday high; largest intraday percent increase on record (Based on available data back to July 10, 2020)

 

All data as of 10:00:51 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 26, 2024 10:03 ET (15:03 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment